Community observations, not medical advice.Always speak with a qualified healthcare professional.
herb × Hormone Health

Ashwagandha for Cortisol Management

Adaptogenic root herb whose withanolide compounds are thought to blunt HPA-axis cortisol release; clinical trials link standardised extracts to reduced perceived stress and anxiety scores.

-published research: study records
-published research: findings
Not formally gradedcertainty of the research
On this pageOverviewEvidenceCommunity outcomesRelated
Why Ashwagandha for Cortisol Management?

The connection

Regulating the body's primary stress hormone. Chronic elevation affects sleep, weight, immune function, and mood.

Also known as: Withania somnifera

Published research

Ashwagandha × Cortisol Management: at a glance

Every published result for this pair, extracted and audited.

Published research

Ashwagandha / Cortisol Management: publication years

What this means: Counts describe research quantity, not treatment effectiveness or certainty.

Ashwagandha / Cortisol Management: publication years (publications, count)
CategoryPublications (count)
20221
20232
20242
20261
← Zoom out: all evidence for AshwagandhaZoom out: compare compounds for Cortisol Management →
Published research

Ashwagandha × Cortisol Management: the evidence base

Hand-selected PubMed studies, linked to the originals.

6studies referenced
6journals
2022–2026publication range

Ordered by strength of evidence, then result direction.

01Effects of ashwagandha (Withania somnifera) on mental health in adults: A systematic review and dose-response meta-analysis of randomized controlled trialsAlsanie SA, et al. · Complementary therapies in medicine · 2026PMID 41644067 ↗02Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta-analysisFatima K, et al. · Human psychopharmacology · 2024PMID 39083548 ↗03Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysisArumugam V, et al. · Explore (New York, N.Y.) · 2024PMID 39348746 ↗04Plant-derived nootropics and human cognition: A systematic reviewLorca C, et al. · Critical reviews in food science and nutrition · 2023PMID 34978226 ↗05Interventions for generalized anxiety disorderByrne GJ · Current opinion in psychiatry · 2023PMID 36705012 ↗06Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) TaskforceSarris J, et al. · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2022PMID 35311615 ↗
Search PubMed ↗View on PubChem ↗Find clinical trials ↗

Community experiences

Contributors volunteered; this does not establish treatment effectiveness or population incidence.

Reported changes

No publishable community breakdown is available. This does not establish that no reports exist.

Share your experience
Important: This page reflects observational, aggregate-only community reporting and independent published research. It is not medical advice, and it does not claim any compound treats, cures, or is effective for any condition. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or treatment.